Condition
Astrocytoma, Grade III clinical trials and research
As of November 12, 2026, Find a Trial lists 4 Astrocytoma, Grade III clinical trials that are recruiting, at sites in 10 countries (most in United States (4), Germany (2), Netherlands (2)). By phase: Phase 1/2 (2), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 10Countries
Newest Astrocytoma, Grade III clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Treatment of high-grade glioma in young patients using olutasidenib and temozolomide | Phase 2 | Aurora, Colorado and 19 other locations | Recruiting | Dec 8, 2023 |
| Comparing two surgical approaches for high-grade glioma patients | — | San Francisco, California and 7 other locations | Recruiting | Nov 7, 2023 |
| Combining Debio 0123 with Temozolomide for Glioblastoma Treatment | Phase 1/2 | Chicago, Illinois and 15 other locations | Recruiting | Mar 13, 2023 |
| Gene therapy and chemotherapy for recurrent glioblastoma | Phase 1/2 | Houston, Texas | Recruiting | Jul 23, 2018 |
All recruiting trials (4)
-
Treatment of high-grade glioma in young patients using olutasidenib and temozolomide
This study is testing if a new combination of olutasidenib and temozolomide can help young patients with high-grade gliomas that have a specific mutation feel better after their radiotherapy.
-
Comparing two surgical approaches for high-grade glioma patients
This study is testing whether a more extensive surgical method for removing high-grade brain tumors helps patients live longer and feel better compared to a standard approach.
-
Combining Debio 0123 with Temozolomide for Glioblastoma Treatment
This study is testing if a new drug called Debio 0123, when combined with the standard treatment temozolomide, can help adults with glioblastoma feel better and improve their outcomes.
-
Gene therapy and chemotherapy for recurrent glioblastoma
This study is testing a new treatment combining gene therapy, a medication, and radiation with chemotherapy to see if it helps people with recurrent glioblastoma or anaplastic astrocytoma who haven't responded to other treatments.
Related topics
Quick answers
How many Astrocytoma, Grade III clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 10 countries. The most sites are in United States (4 trials), Germany (2 trials), Netherlands (2 trials), Switzerland (2 trials), Belgium (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 2, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.